The short version
- Why people research itOvarian and female hormonal ageing — the A-series counterpart to Testoluten.
- What the evidence isNo randomized human trials — a research compound with no commercial route to funding one, so the correlative and theoretical tiers are the evidence base rather than a consolation prize.
- What to watchSpotting or irregular bleeding.
How Zhenoluten works
The proposal is tissue specificity: a short peptide fraction taken from one organ acts preferentially on that same organ, binding regulatory DNA sequences and shifting protein synthesis toward a younger pattern.
Khavinson-school organ peptide extracts. The claim is tissue specificity: a short peptide fraction from one organ is proposed to act on that same organ, restoring its protein synthesis toward a younger pattern by binding regulatory DNA sequences. The mechanism is coherent and the human evidence for it is thin outside the group that proposed it.
- Oral
On the goal map: Perimenopause & the estrogen decline (Female hormonal balance)
Research on Zhenoluten4 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: Theoretical — Khavinson-school work, largely Russian-language and rarely replicated outside it.
Human clinical evidence
No randomized human trials — a research compound with no commercial route to funding one, so the correlative and theoretical tiers are the evidence base rather than a consolation prize.
No completed human trial
Correlative data
The Khavinson group reported improvements in organ-specific markers across a long series of studies from the 1980s onward. These are overwhelmingly small, single-arm, and published in Russian-language journals; independent replication outside that school is close to absent.
How the mechanism reads
The proposal is tissue specificity: a short peptide fraction taken from one organ acts preferentially on that same organ, binding regulatory DNA sequences and shifting protein synthesis toward a younger pattern.
MechanisticOral delivery is the open question, not the mechanism. Peptides are poorly absorbed intact from the gut. Whether enough survives to reach the target tissue has not been shown in a way anyone outside the manufacturer can check.
Mechanistic
Sources
- Gadzhieva TS. Effect of epithalamin on hypophyseal and ovarian gonadotropic function. Akusherstvo i Ginekologiia (Moskva) 1980 [Russian] · PMID 7192059
- Komarov FI. Use of epithalamin in climacteric myocardiopathy. Klinicheskaia Meditsina (Moskva) 1995 [Russian] · PMID 7474816
- Ryzhak AP, Chalisova NI, Lin'kova NS, Khalimov RI, Ryzhak GA, Zhekalov AN. [Polypeptides influence on tissue cell cultures regeneration of various age rats]. Advances in Gerontology 2015;28(1):97-103 [Russian] · PMID 26390619
- Khavinson VKh. Peptides tissue-specifically stimulate cell differentiation during their aging. Bulletin of Experimental Biology and Medicine 2012 · PMID 22808515
- Khavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021;26(22):7053 · PMID 34834147
Zhenoluten safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Estrogen-sensitive breast, ovarian or uterine cancer: an ovary-derived extract could carry hormonal signals.
- Unexplained vaginal bleeding, which needs a cause found before any ovarian extract.
- Animal protein allergy: it is an ovarian peptide fraction.
- Pregnancy or conception plans: an ovarian extract could carry hormone signals.
- Past clot linked to hormone use.
What’s expected
- Probably nothing felt; the claim is slow support of ovarian tissue, mostly from its own school.
- Mild digestive upset while using Zhenoluten.
- Any hormone effect would show on labs first.
Watch for
- Spotting or irregular bleeding.
- A breast lump.
- Calf swelling while using Zhenoluten.
- Hives while using Zhenoluten.
Labs that tell you it’s working
- Estradiol, Sensitive [LC/MS-MS]
- FSH (Follicle-Stimulating Hormone)
- Anti-Mullerian Hormone (AMH)
- Progesterone [LC/MS]
Zhenoluten (A-15) is an oral ovarian peptide fraction with thin evidence outside its school; sex hormone labs are the check.
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Zhenoluten FAQ4 common questions
- Is Zhenoluten approved for human use?
- No. Zhenoluten is a research compound. No completed randomized human trial has given it yet.
- What is Zhenoluten researched for?
- Ovarian and female hormonal ageing — the A-series counterpart to Testoluten.
- Which labs show whether it's doing anything?
- Estradiol, Sensitive [LC/MS-MS]; FSH; Anti-Mullerian Hormone; Progesterone [LC/MS]: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Zhenoluten: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



